arBtrage CAPITALIZING MARKETS checking… Sign in

Pfizer, Inc.

PFE Health Care Biotechnology: Pharmaceutical Preparations
$26.04
▲ +1.4% Today
as of Jun 7, 07:24 ET
Last 30 days -1.66% Apr 28 → Jun 05
$25.22 $25.62 $26.02 $26.41 $26.81 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$25.85
High
$26.21
Low
$25.79
Volume
$32M
Avg Vol
$48M
Mkt Cap
$149.0B
P/E (TTM)
16.27
Beta
52w High
$28.75
52w Low
$23.08
Div Yield
Shares Out

Overview

52-week range
$23
$29
52% of range
Avg surprise (last 2)
+24.7%
Avg reaction (last 2)
+1.9%
100% positive
Latest IV / EM
30%
EM ±2.8% · $26 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.42$-0.08$0.25$0.59$0.92 Actual $0.41Actual $-0.42Actual $0.55Actual $0.01Actual $0.78Actual $0.92Est $0.64Actual $0.51Actual $0.62Actual $0.75Est $0.71 JulOctMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$0$4.6B$9.3B$13.9B$18.6B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $0.75 $0.71 +5.6% -18.5% +0.6% earnings
Sun Sep 28, 2025Sep 2025 $0.62 financials
Sun Jun 29, 2025Jun 2025 $0.51 financials
Tue Apr 29, 2025Mar/2025 $0.92 $0.64 +43.8% +3.2% earnings
Sun Sep 29, 2024Sep 2024 $0.78 financials
Sun Jun 30, 2024Jun 2024 $0.01 financials
Sun Mar 31, 2024Mar 2024 $0.55 financials
Sun Oct 1, 2023Oct 2023 $-0.42 financials
Sun Jul 2, 2023Jul 2023 $0.41 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$14.45B$16.65B$14.65B$13.71B$17.70B$13.28B
Cost of revenue$3.55B$4.17B$3.78B$2.85B$5.26B$3.30B
Gross profit
Operating income
Net income$2.69B$3.54B$2.91B$2.97B$4.46B$41M
EPS (diluted)$0.47$0.62$0.51$0.52$0.78$0.01

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$1.70B$1.14B$1.34B$1.64B$1.43B$1.04B$1.09B$1.05B
Inventory$10.67B$10.65B$11.47B$11.67B$10.85B$10.85B$11.72B$11.45B
Total current assets$42.82B$42.90B$46.92B$43.70B$45.86B$50.36B$43.22B$37.83B
Total assets$207.62B$208.16B$208.73B$206.09B$208.03B$213.40B$219.48B$216.19B
Long-term debt$60.56B$61.64B$57.41B$57.50B$57.64B$57.41B$58.00B$57.51B
Total liabilities$117.21B$121.39B$115.64B$117.08B$117.39B$124.90B$126.92B$128.22B
Total equity$90.10B$86.48B$92.80B$88.69B$90.34B$88.20B$92.29B$87.70B

Implied volatility — last 90 days

25%27%30%32%35% Jun 07 — IV 30% · EM ±2.8%

Sector peers